8-(Furan-2-yl)-3-phenethylthiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione as novel, selective and potent adenosine A2A receptor antagonist-Reference-Cited by-同舟云学术

8-(Furan-2-yl)-3-phenethylthiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione as novel, selective and potent adenosine A2A receptor antagonist

Published:2014-01 Issue: Volume:558 Page:203-207
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Kumari Namrata,Mishra Chandra Bhushan,Prakash Amresh,Kumar Nitin,Mongre Rajkumar,Luthra Pratibha Mehta

Publisher

Elsevier BV

Subject

General Neuroscience

Reference21 articles.

1. Functional changes of the basal ganglia circuitry in Parkinson's disease;Blandini;Prog. Neurobiol.,2000

2. Antagonism of haloperidol-induced swim impairments in L-dopa and caffeine treated mice: a pre-clinical model to study Parkinson's disease;Luthra;J. Neurosci. Methods,2009

3. Plausible improvements for selective targeting of dopamine receptors in therapy of PD;Luthra;Mini-Rev. Med. Chem.,2012

4. Adenosine in the central nervous system: release mechanisms and extracellular concentrations;Latini;J. Neurochem.,2001

5. Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: implications for the treatment of dyskinesia in Parkinson's disease;Chen;Neurology,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multitarget action of Benzothiazole-piperazine small hybrid molecule against Alzheimer's disease: In silico, In vitro, and In vivo investigation;Biomedicine & Pharmacotherapy;2024-05

2. Phosphine-Mediated [3+2] Cyclization for the Synthesis of Coumarin-Based CF3-Containing Furanones;Synlett;2023-04-05

3. Adenosine A2A Receptor Antagonists: Chemistry, SARs, and Therapeutic Potential;Topics in Medicinal Chemistry;2023

4. Access to 5‐Substituted 3‐Aminofuran/Thiophene‐2‐Carboxylates from Bifunctional Alkynenitriles;Advanced Synthesis & Catalysis;2022-05-24

5. Adenosine receptor antagonists: Recent advances and therapeutic perspective;European Journal of Medicinal Chemistry;2022-01